Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Company DECO (LLC Company DECO) is a Russian pharmaceutical manufacturing company founded in 1995 and headquartered in Moscow, with its main production facility located in Zelenogorsky, Tver Oblast. The company specializes in the development and manufacture of a wide range of pharmaceutical products, including antibiotics (such as Meropenem and Ceftriaxone), oncology therapeutics (such as Aranoza and Lizomustin), analgesics, and peptide-based drugs (such as Octreotide). In addition to producing its own proprietary and generic drug portfolio, Company DECO operates as a contract manufacturing organization (CMO) for other pharmaceutical companies, providing sterile and non-sterile drug formulation services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Empresa DECO.